Non-stroke neurological syndromes associated with antiphospholipid antibodies: Evaluation of clinical and experimental studies

J. Chapman, J. H. Rand, R. L. Brey, S. R. Levine, I. Blatt, M. A. Khamashta, Y. Shoenfeld

Resultado de la investigación: Articlerevisión exhaustiva

85 Citas (Scopus)

Resumen

Although many types of neurological disorders and events have been described in association with antiphospholipid antibodies (aPL) and the antiphospholipid syndrome (APS), only ischaemic stroke is reasonably well established and accepted as a diagnostic criterion for the syndrome. We propose to evaluate, classify and rank the association of other neurological manifestations as possible, probable, or definite according to the data available from clinical studies and animal models. By these criteria, none of the neurological disorders or events such as epilepsy, psychiatric disease, dementia, transverse myelitis, multiple sclerosis-like disease, chorea, migraine, Guillian-Barrè syndrome, and sensory-neural hearing loss, can be definitely associated with aPL or APS.

Idioma originalEnglish (US)
Páginas (desde-hasta)514-517
Número de páginas4
PublicaciónLupus
Volumen12
N.º7
DOI
EstadoPublished - 2003

ASJC Scopus subject areas

  • Rheumatology

Huella

Profundice en los temas de investigación de 'Non-stroke neurological syndromes associated with antiphospholipid antibodies: Evaluation of clinical and experimental studies'. En conjunto forman una huella única.

Citar esto